Advertisement

Topics

SmartZyme BioPharma, Inc. Company Profile

04:31 EDT 27th June 2019 | BioPortfolio

SmartZyme BioPharma, Inc. is a New York-based OrbiMed portfolio company that specializes in researching and developing optimized protein, enzyme, and mRNA therapeutics through directed evolution. SmartZyme’s current portfolio includes a next-generation, ultra-accurate, glucose-sensing enzyme that undergoes direct-electron transfer which has been integrated into a sensor for use in continuous glucose monitors (CGM); and a next-generation recombinant Factor VIIa protein for acute bleeding episodes. Smartzyme is currently evaluating other potential innovative drug programs for global development.


News Articles [1070 Associated News Articles listed on BioPortfolio]

SmartZyme spins off Carnot

SmartZyme BioPharma Inc. has spun off its protein engineering platform into a new company named Carnot BioSciences LLC.

#news #biotech SmartZyme spins off protein tech company for a metabolic disease partnership with Hemoshear

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: SmartZyme spins off protein tech company for a metabolic disease partnership ...

Deals this week: Argenx, SmartZyme BioPharma, Viracta Therapeutics

Argenx will develop and license its cancer drug candidate cusatuzumab (ARGX-110) after partnering with Janssen Pharmaceutical’s affiliate company Cilag International. The two...Read More... The po...

SmartZyme spin-off Carnot teams up with HemoShear

SmartZyme BioPharma Inc. has spun off its protein engineering platform into a new company named Carnot BioSciences LLC to collaborate with HemoShear Therapeutics LLC on the development of protein-base...

Carnot BioSciences, a Spin off of SmartZyme BioPharma, and Hemoshear Therapeutics Partner to Develop Protein-Based Therapeutics for Rare Metabolic Diseases

SmartZyme BioPharma Spins Off Protein Engineering Platform into Carnot BioSciences; with the New Company’s Leadership Team Comprised of Former Synageva Scientists ...

KBI Biopharma: How to stand out in the CMO space

KBI Biopharma is a CMO focused exclusively on biologics. Bernardo Estupinan-Gaisbauer, Vice President – Business Development at KBI Biopharma, discusses their strategy for partnering, and the challe...

MilliporeSigma Tech Talk: Biopharma Recycling Program

SOURCE: MilliporeSigma DESCRIPTION:See how we're changing the way the world looks at single-use waste with the Biopharma Recycling Program. For more information, visit our website.  Tweet me: In ho...

Danaher acquires GE biopharma for $21.4 billion

General Electric is selling its biopharma business for $21.4 billion, with shares in the company jumping 16 percent upon the news... The post Danaher acquires GE biopharma for $21.4 billion appeared f...

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Alferon [hemispherx biopharma, inc]

NA

Yupelri [the ritedose corporation]

Yupelri (Revefenacin) Inhalation Solution 175 mcg/3 mL

Keveyis [strongbridge us inc.]

These highlights do not include all the information needed to use KEVEYIS safely and effectively. See full prescribing information for KEVEYIS. KEVEYIS (dichlorphenamide) tablets, for oral use Initial...

Macrilen [strongbridge u.s. inc]

These highlights do not include all the information needed to use MACRILEN safely and effectively. See full prescribing information for MACRILEN.MACRILEN (macimorelin) for oral solution Initial U.S. A...

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

PubMed Articles [7 Associated PubMed Articles listed on BioPortfolio]

Biopharma dealmaking in 2018.

Correction to: Revefenacin: First Global Approval.

The article Revefenacin: First Global Approval, written by Young-A Heo, was originally published Online First without open access. After publication in volume 79, issue 1, pages 85-91, Mylan Inc. (Can...

Native and Denaturing MS Protein Deconvolution for Biopharma: Monoclonal Antibodies and Antibody-Drug-Conjugates to Polydisperse Membrane Proteins and Beyond.

Electrospray ionization mass spectrometry (ESI-MS) is a ubiquitously used analytical method applied across multiple departments in biopharma, ranging from early Research Discovery to Process Developme...

Data science tools and applications on the way to Pharma 4.0.

Multiple obstacles are driving the digital transformation of the biopharmaceutical industry. Novel digital techniques, often marketed as 'Pharma 4.0', are thought to solve some long-existing obstacles...

Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence Generation.

At the turn of the century, the pharmaceutical industry began a transition toward a focus on oncology, rare diseases, and other areas of high unmet need that required a new, more complex approach to d...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Single Ascending Dose Phase 1 Trial in Patients With Type 2 Diabetes

ARRY-403 is an investigational new drug being developed by Array BioPharma Inc. for treating Type 2 diabetes. The purpose of this study is to test the safety (potential side effects) and ...

A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a ma...

Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a ma...

Companies [154 Associated Companies listed on BioPortfolio]

SmartZyme BioPharma, Inc.

SmartZyme BioPharma, Inc. is a New York-based OrbiMed portfolio company that specializes in researching and developing optimized protein, enzyme, and mRNA therapeutics through dir...

SmartZyme

SmartZyme is a privately held biopharmaceutical company focused on its Provolution™ proprietary technological platform for protein design and engineering, in accordance with ...

SAFE-BioPharma Association

SAFE-BioPharma Association (www.safe-biopharma.org) is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the ...

Kedrion Biopharma, Inc.

Kedrion Biopharma is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and pre...

Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is a development-stage biotechnology company engaged primarily in the development of targeted cancer therapies. For more information on the Company, visit http://www.genesis-b...

More Information about "SmartZyme BioPharma, Inc." on BioPortfolio

We have published hundreds of SmartZyme BioPharma, Inc. news stories on BioPortfolio along with dozens of SmartZyme BioPharma, Inc. Clinical Trials and PubMed Articles about SmartZyme BioPharma, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SmartZyme BioPharma, Inc. Companies in our database. You can also find out about relevant SmartZyme BioPharma, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...


Corporate Database Quicklinks



Searches Linking to this Company Record